Oscar Health (OSCR) Liabilities and Shareholders Equity (2020 - 2026)

Oscar Health's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $9.3 billion for Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 58.97% year-over-year to $9.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.7 billion (up 37.53% YoY) and the FY2025 annual result came in at $6.3 billion, up 30.68% from the prior year.
• Liabilities and Shareholders Equity was $9.3 billion for Q1 2026 at Oscar Health, up from $6.3 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $9.3 billion in Q1 2026 and bottomed at $3.3 billion in Q3 2023.
• A 5-year average of $5.1 billion and a median of $4.6 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity decreased 22.26% — and 2026, when it surged 58.97%.
• Oscar Health's Liabilities and Shareholders Equity stood at $4.5 billion in 2022, then slipped by 20.44% to $3.6 billion in 2023, then surged by 34.4% to $4.8 billion in 2024, then jumped by 30.68% to $6.3 billion in 2025, then surged by 46.86% to $9.3 billion in 2026.
• Business Quant data shows OSCR's Liabilities and Shareholders Equity at $9.3 billion in Q1 2026, $6.3 billion in Q4 2025, and $5.7 billion in Q3 2025.